BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 15606829)

  • 1. Cutis laxa: Improvement of facial aesthetics by using botulinum toxin.
    Tamura BM; Lourenço LM; Platt A; Pertel P; Santos LF; Levites J
    Dermatol Surg; 2004 Dec; 30(12 Pt 2):1518-20. PubMed ID: 15606829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired localized cutis laxa confined to the face: case report and review of the literature.
    Riveros CJ; Gavilán MF; França LF; Sotto MN; Takahashi MD
    Int J Dermatol; 2004 Dec; 43(12):931-5. PubMed ID: 15569023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalized acquired cutis laxa type 1: a case report and brief review of literature.
    Kumar P; Savant SS; Das A
    Dermatol Online J; 2016 Mar; 22(3):. PubMed ID: 27136630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Can the botulinum toxin prevent aging?].
    Le Louarn C
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S92-103. PubMed ID: 19576493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Botulin toxin injections in cosmetic treatment of men].
    Gassia V
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S119-24. PubMed ID: 19576477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired localized cutis laxa of the face: a rare presentation.
    Mehta B; Amladi S
    Pediatr Dermatol; 2011; 28(4):421-3. PubMed ID: 21362028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cutis laxa. Classification, clinical aspects and molecular defects].
    Mensing H; Krieg T; Meigel W; Braun-Falco O
    Hautarzt; 1984 Oct; 35(10):506-11. PubMed ID: 6500933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxins for facial wrinkles: beyond glabellar lines.
    Dayan SH; Maas CS
    Facial Plast Surg Clin North Am; 2007 Feb; 15(1):41-9, vi. PubMed ID: 17317554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Botulinum toxin in disabling dermatological diseases].
    Messikh R; Atallah L; Aubin F; Humbert P
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S129-36. PubMed ID: 19576479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
    Rzany B; Ascher B; Fratila A; Monheit GD; Talarico S; Sterry W
    Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of intradermal botulinum toxin to reduce sebum production and facial pore size.
    Shah AR
    J Drugs Dermatol; 2008 Sep; 7(9):847-50. PubMed ID: 19112798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutis laxa acquisita associated with cutaneous mastocytosis.
    Mahajan VK; Sharma NL; Garg G
    Int J Dermatol; 2006 Aug; 45(8):949-51. PubMed ID: 16911382
    [No Abstract]   [Full Text] [Related]  

  • 13. [Management of axillary hyperhidrosis].
    Pomarède N
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S125-8. PubMed ID: 19576478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Botulinum toxin injection techniques in the lower third and middle of the face, the neck and the décolleté: the "Nefertiti lift"].
    Gassia V; Beylot C; Béchaux S; Michaud T
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S111-8. PubMed ID: 19576476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Controversy: botulinum toxin, does it prevent cutaneous aging?].
    Cohen-Letessier A
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S89-91. PubMed ID: 19576492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermal and epidermal remodeling using botulinum toxin type A for facial, non reducible, hyperkinetic lines: two case studies.
    Bowler PJ
    J Cosmet Dermatol; 2008 Sep; 7(3):241-4. PubMed ID: 18789065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on botulinum toxin.
    Flynn TC
    Semin Cutan Med Surg; 2006 Sep; 25(3):115-21. PubMed ID: 17055389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, evaluator-blinded, two-center study of the safety and effect of volume on the diffusion and efficacy of botulinum toxin type A in the treatment of lateral orbital rhytides.
    Carruthers A; Bogle M; Carruthers JD; Dover JS; Arndt KA; Hsu TS; Poirier J
    Dermatol Surg; 2007 May; 33(5):567-71. PubMed ID: 17451579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Frey's syndrome with botulinum toxin.
    Pomprasit M; Chintrakarn C
    J Med Assoc Thai; 2007 Nov; 90(11):2397-402. PubMed ID: 18181326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Congenital generalized cutis laxa].
    Lambert D; Beer F; Jeannin-Magnificat C; Mabille JP; Israël J; Lambert-Weyl M; Nivelon-Chevalier A; Alison M
    Ann Dermatol Venereol; 1983; 110(2):129-38. PubMed ID: 6881855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.